Is Catalyst Pharmaceuticals, Inc. (CPRX) a Buy, Sell, or Hold?
NASDAQ : CPRX
Catalyst Pharmaceuticals, Inc. — Analyst Ratings
$31.49 USD
$0 (0.0%)
- Volume
- 0
- Average Volume
- 3.01M
- Market Capitalization
- $3.85B
- P/E Ratio
- 17.49
- Dividend Yield
- 0.00%
- Price Target
- $31.75
- Year High
- $32.56
- Year Low
- $19.05
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $7.10
Analyst Consensus Summary
Consensus Rating
N/A
16 Analysts
Rating Score
0/5
Recommendation Strength
Upside/Downside
-0.8%
vs Current Price
Price Target
$31.75
Average TargetPrice Target Range
Lowest Target
$31.50
0.0% DOWNSIDE
Average Target
$31.75
Median Estimate
Highest Target
$32.00
-1.6% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 16
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 12 | 4 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Oppenheimer | Leland Gershell | $33 | $21.66 | 2025-11-07 08:30 AM | 52.4% |
| Robert W. Baird | Joel Beatty | $28 | $23.09 | 2025-02-04 05:11 AM | 21.3% |
| H.C. Wainwright | Andrew Fein | $35 | $21.92 | 2025-01-10 06:18 AM | 59.7% |
| Piper Sandler | Joseph Catanzaro | $20 | $16.41 | 2022-12-19 03:32 PM | 21.9% |
| Roth Capital | Scott Henry | $15.5 | $14.91 | 2022-08-24 01:02 AM | 4.0% |